Glycan Shielding of the Influenza Virus Hemagglutinin Contributes to Immunopathology in Mice
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
RATIONALE: Pandemic influenza viruses historically have had few potential sites for N-linked glycosylation on the globular head of the hemagglutinin (HA) on emergence from the avian reservoir. Gain of glycans within antigenic sites of the HA during adaptation to the mammalian lung facilitates immune evasion. OBJECTIVES: In this study, we sought to determine in mice how exposure to highly glycosylated viruses affects immunity to poorly glycosylated variants to model the emergence of a novel pandemic strain of a circulating subtype. METHODS: We engineered the 1968 H3N2 pandemic strain to express an additional two or four potential sites for glycosylation on the globular head of the HA. Mice were infected sequentially with highly glycosylated variants followed by poorly glycosylated variants and monitored for immune responses and disease. MEASUREMENTS AND MAIN RESULTS: The mutant with four additional glycosylation sites (+4 virus) elicited significantly lower antibody responses than the wild-type or +2 virus and was unable to elicit neutralizing antibodies. Mice infected with the +4 virus and then challenged with wild-type virus were not protected from infection and experienced significant T-cell-mediated immunopathology. Infection with a recent seasonal H1N1 virus followed by infection with the 2009 pandemic H1N1 elicited similar responses. CONCLUSIONS: These data suggest that sequential infection with viral strains with different surface glycosylation can prime the host for immunopathology if a neutralizing antibody response matching the T-cell response is not present. This mechanism may have contributed to severe disease in young adults infected with the 2009 pandemic virus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Critically Ill Patients With 2009 Influenza A(H1N1) Infection in Canada
Kumar, A. (2009) · JAMA · doi:10.1001/jama.2009.1496 · Cited by 1,425 · cited 1×
“This pandemic has been characterized by sparing of elderly persons, who have cross-reactive antibodies from exposure to antigenically similar and poorly glycosylated H1N1 viruses in childhood (11, 15, 16), but high clinical attack rates and unusual, severe lower respiratory tract infections in healthy children and you…”
BackgroundPneumonia and Respiratory Failure from Swine-Origin Influenza A (H1N1) in Mexico
Perez-Padilla, R., de la Rosa-Zamboni, D., Ponce de Leon, S., Hernandez, M., Quiñones-Falconi, F., Bautista, E., Ramirez-Venegas, A., Rojas-Serrano, J., Ormsby, C. E., Corrales, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0904252 · Cited by 1,325 · cited 6×
“During the course of this work, a new pandemic of the H1N1 subtype emerged (14), providing a direct test of this hypothesis in the human population.”
BackgroundInfluentialCritically Ill patients with 2009 influenza A(H1N1) in Mexico
Domínguez-Cherit, G. (2009) · JAMA · doi:10.1001/jama.2009.1536 · Cited by 840 · cited 1×
“This pandemic has been characterized by sparing of elderly persons, who have cross-reactive antibodies from exposure to antigenically similar and poorly glycosylated H1N1 viruses in childhood (11, 15, 16), but high clinical attack rates and unusual, severe lower respiratory tract infections in healthy children and you…”
BackgroundLung Pathology in Fatal Novel Human Influenza A (H1N1) Infection
Mauad, T., Hajjar, L. A., Callegari, G. D., da Silva, L. F. F., Schout, D., Galas, F. R. B. G., Alves, V. A. F., Malheiros, D. M. A. C., Auler, J. O. C., Ferreira, A. F., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200909-1420oc · Cited by 547 · cited 2×
“Tracheitis, bronchitis, and diffuse alveolar damage have been the most common findings, often in conjunction with characteristic pathology related to superimposed secondary bacterial infections (32, 33).”
BackgroundPulmonary Pathologic Findings of Fatal 2009 Pandemic Influenza A/H1N1 Viral Infections
Gill, J. R., Sheng, Z.-M., Ely, S. F., Guinee, D. G., Beasley, M. B., Suh, J., Deshpande, C., Mollura, D. J., Morens, D. M., Bray, M., et al. (2010) · Archives of Pathology & Laboratory Medicine · doi:10.5858/134.2.235 · Cited by 426
McAuley, J. L., Hornung, F., Boyd, K. L., Smith, A. M., McKeon, R., Bennink, J., Yewdell, J. W., & McCullers, J. A. (2007) · Cell Host & Microbe · doi:10.1016/j.chom.2007.09.001 · Cited by 389 · cited 2×
“A semiquantitative grading scheme was used to score two parameters: the overall character of the pneumonic process and the pathology specifically observed in the interstitium and terminal airways as described (21).”
MethodGlycans on influenza hemagglutinin affect receptor binding and immune response
Wang, C.-C., Chen, J.-R., Tseng, Y.-C., Hsu, C.-H., Hung, Y.-F., Chen, S.-W., Chen, C.-M., Khoo, K.-H., Cheng, T.-J., Cheng, Y.-S. E., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909696106 · Cited by 316 · cited 2×
“The ability of glycans to mask antibody epitopes has been previously demonstrated using monoclonal antibody and vaccine approaches (4, 26), but the consequences of sequential infections as happen in humans over time had not been explored.”
Background
Cited by
Exploitation of glycosylation in enveloped virus pathobiology
Watanabe, Y., Bowden, T. A., Wilson, I. A., & Crispin, M. (2019) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2019.05.012 · Cited by 482
Tate, M., Job, E., Deng, Y.-M., Gunalan, V., Maurer-Stroh, S., & Reading, P. (2014) · Viruses · doi:10.3390/v6031294 · Cited by 263
Two Years after Pandemic Influenza A/2009/H1N1: What Have We Learned?
Cheng, V. C. C., To, K. K. W., Tse, H., Hung, I. F. N., & Yuen, K.-Y. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05012-11 · Cited by 223
Fitness costs limit influenza A virus hemagglutinin glycosylation as an immune evasion strategy
Das, S. R., Hensley, S. E., David, A., Schmidt, L., Gibbs, J. S., Puigbò, P., Ince, W. L., Bennink, J. R., & Yewdell, J. W. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108754108 · Cited by 143
“This finding extends previous findings that glycosylation modulates HA antigenicity (12, 13, 19) and immunogenicity (20).”
ResultBitter-sweet symphony: glycan–lectin interactions in virus biology
Van Breedam, W., Pöhlmann, S., Favoreel, H. W., de Groot, R. J., & Nauwynck, H. J. (2014) · FEMS Microbiology Reviews · doi:10.1111/1574-6976.12052 · Cited by 141
Metadata
- Authors
- Wanzeck, K., Boyd, K. L., & McCullers, J. A.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-03-15
- Volume
- 183
- Issue
- 6
- Pages
- 767-773
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2141787031
- Cited by
- 90
- References
- 7
- FWCI
- 3.77
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Glycan Shielding of the Influenza Virus Hemagglutinin Contributes to Immunopathology in Mice. https://app.cochat.ai/papers/10.1164/rccm.201007-1184oc
- The paper
- Wanzeck, K., Boyd, K. L., & McCullers, J. A. (2011). Glycan Shielding of the Influenza Virus Hemagglutinin Contributes to Immunopathology in Mice. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/rccm.201007-1184oc
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.